Faculty Publications
As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.
Total number of publications: 7,082
Enter a faculty name:
or browse faculty by school:
Administrative Offices
Graduate Schools
Health Sciences
Lander Colleges
Law Center
New York School of Career and Applied Studies (NYSCAS)
Touro University System
New York Medical College (NYMC)
Touro University California
Touro University Nevada
Goldman, S., Smith, L., Anderson, J. R., Perkins, S., Harrison, L., Geyer, M. B., . . . Cairo, M. S. (2013). Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report. Leukemia, 27(5), 1174-1177. doi:10.1038/leu.2012.255
Goldman, S., Smith, L., Galardy, P., Perkins, S. L., Frazer, J. K., Sanger, W., . . . Cairo, M. S. (2014). Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: A Children's Oncology Group report. British Journal of Haematology, 167(3), 394-401. doi:10.1111/bjh.13040
Golombek, S. G., & Sola, A. (2015). Patent ductus arteriosus in preterm neonates-concerns with some recommendations. JAMA Pediatrics, 169(12), [Article 1177]. doi:10.1001/jamapediatrics.2015.2789
Golombek, S. G., Suttner, D., Ehrlich, R., & Potenziano, J. (2014). Target versus actual oxygenation index at initiation of inhaled nitric oxide in neonates with hypoxic respiratory failure: Survey results from 128 patient cases. Journal of Perinatal Medicine, 42(6), 685-692. doi:10.1515/jpm-2014-0242
Gordon, A. S., Tabor, H. K., Johnson, A. D., Snively, B. M., Assimes, T. L., Auer, P. L., Ioannidis, J. P., Peters, U., Robinson, J. G., Sucheston, L. E., Wang, D., Sotoodehnia, N., Rotter, J. I., Psaty, B. M., Jackson, R. D., Herrington, D. M., O'Donnell, C. J., Reiner, A. P., Rich, S. S., Rieder, M. J., Bamshad, M. J., Nickerson, D. A., & NHLBI GO Exome Sequencing Project (including Dozor,A.J.) (2014 ). Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset. Human Molecular Genetics, 23(8), 1957-1963. doi:10.1093/hmg/ddt588
Gripp, K. W., Curry, C., Olney, A. H., Sandoval, C., Fisher, J., Chong, J. X , . . . Sol-Church, K. (2014). Diamond-Blackfan anemia with mandibulofacial dystostosis is heterogeneous, including the novel DBA genes TSR2 and RPS28. American Journal of Medical Genetics. Part A, 164A(9), 2240-2249. doi:10.1002/ajmg.a.36633
Gupta-Malhotra, M., Kern, J. H., Flynn, P. A., Schiller, M. S., Quaegebeur, J. M., & Friedman, D. M. (2013). Cardiac troponin I after cardiopulmonary bypass in infants in comparison with older children. Cardiology in the Young, 23(3), 431-435. doi:10.1017/S1047951112001163
Gupta, T., Khera, S., Harikrishnan, P., Aronow, W., Jain, D., Sule, S., Cooper, H., Frishman, W., . . . Panza, J. (2016). Does the smoker's paradox exist in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention? Journal of the American College of Cardiology, 67(13 (Suppl 5)), 441. doi:10.1016/S0735-1097(16)30442-9
Hahn, S., Pena, L., Day, J. W., Gambello, M., Gibson, J. B., Kronn, D., . . . Pompe ADVANCE Study Consortium. (2016). 52-week efficacy and safety profile of alglucosidase alfa produced at 4000 liter scale in US patients with Pompe disease: ADVANCE, a phase 4 open-label prospective study. Molecular Genetics and Metabolism, 117(2), S54. doi:10.1016/j.ymgme.2015.12.281
Hale, G. A., Arora, M., Ahn, K. W., He, W., Camitta, B., Bishop, M. R., . . . Cairo, M. S. (2013). Allogeneic hematopoietic cell transplantation for neuroblastoma: The CIBMTR experience. Bone Marrow Transplantation, 48(8), 1056-1064. doi:10.1038/bmt.2012.284
Hamadani, M., Saber, W., Ahn, K. W., Carreras, J., Cairo, M. S., Fenske, T. S., . . . Lazarus, H. M. (2013). Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: A cohort analysis from the Center for International Blood and Marrow Transplant Research. Biology of Blood and Marrow Transplantation, 19(4), 625-631. doi:10.1016/j.bbmt.2013.01.009
Hamadani, M., Saber, W., Ahn, K. W., Carreras, J., Cairo, M. S., Fenske, T. S., . . . Lazarus, H. M. (2013). Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma. Biology of Blood and Marrow Transplantation, 19(5), 746-753. doi:10.1016/j.bbmt.2013.01.024
Hamill, D., Baxter-Lowe, L. A., Shenoy, S., Moore, T. B., Morris, E., Abikoff, C., . . . Cairo, M. S. (2016). Robust donor chimerism and engraftment following familial haploidentical (FHI) (CD34 enriched and T-cell addback) allogeneic stem cell transplantation in patients with high risk sickle cell disease (SCD). Biology of Blood and Marrow Transplantation, 22(3), S95-S96. doi:10.1016/j.bbmt.2015.11.396
Hills, L. B., Masri, A., Konno, K., Kakegawa, W., Lam, A. T., Lim-Melia, E., . . . Chandy, N. (2013). Deletions in GRID2 lead to a recessive syndrome of cerebellar ataxia and tonic upgaze in humans. Neurology, 81(16), 1378-1386. doi:10.1212/WNL.0b013e3182a841a3
Hitzler, J. K., He, W., Doyle, J., Cairo, M., Camitta, B. M., Chan, K. W., . . . CIBMTR Pediatric Cancer Working Committee. (2014). Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. Pediatric Blood & Cancer, 61(6), 1126-1128. doi:10.1002/pbc.24918
Hitzler, J. K., He, W., Doyle, J., Cairo, M. S., Camitta, B. M., Chan, K. W., . . . Carpenter, P. A. (2013). Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome. Biology of Blood and Marrow Transplantation, 19(6), 893-897. doi:10.1016/j.bbmt.2013.02.017
Hochberg, J. C., Cairo, M. S., & Friedman, D. M. (2014). Cardio-oncology issues among pediatric cancer and stem cell transplant survivors. Cardiology in Review, 22(6), 268-274. doi:10.1097/CRD.0000000000000030
Hochberg, J. C., El-Mallawany, N. K., & Cairo, M. S. (2014). Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults. Clinical Lymphoma, Myeloma & Leukemia, 14(Suppl.), S6-S13. doi:10.1016/j.clml.2014.04.015
Hochberg, J., El-Mallawany, N. K., & Abla, O. (2016). Adolescent and young adult non-Hodgkin lymphoma. British Journal of Haematology, 173(4), 637-650. doi:10.1111/bjh.14074
Hochberg, J., Harrison, L., Morris, E., Militano, O., Brand, P., Fabricatore, S., . . . Cairo, M. S.. (2016). Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-Hodgkin lymphoma. Bone Marrow Transplantation, 51(9), 1249-1252. doi:10.1038/bmt.2016.100
Hochberg, J., Harrison, L., Morris, E., Militano, O., Brand, P., Fabricatore, S., . . . Cairo, M. S. (2016). Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-hodgkin lymphoma. Bone Marrow Transplantation, 51(9), 1249-1252. doi:10.1038/bmt.2016.100
Hochberg, J., Oesterheld, J., Militano, O., Klejmont, L., Harrison, L., Nickerson, B., & Cairo, M. (2016). Final phase I results of mitoxantrone in combination with clofarabine in children with refractory/relapsed acute leukemia. Pediatric Blood & Cancer, 63(Suppl S1), S7. doi:10.1002/pbc.25998
Hochberg, J., Oesterheld, J., Militano, O., Klejmont, L., Harrison, L., Nickerson, B., & Cairo, M. (2016). Phase I results of mitoxantrone in combination with clofarabine in children, adolescents and young adults with refractory/relapsed acute leukemia. Pediatric Blood & Cancer, 63(Suppl 3), S108. doi:10.1158/1538-7445.AM2016-3203
Hochberg, J., Oesterheld, J., Militano, O., Klejmont, L., Harrison, L., Nickerson, B., & Cairo, M. S. (2016). Phase I results of mitoxantrone in combination with clofarabine in children with refractory/relapsed acute leukemia. Cancer Research, 76(14 (Suppl)), 3203. doi:10.1158/1538-7445.AM2016-3203
Hsu, C. D., Polavarapu, S., & Parton, L. (2012). Are placental fas and fas ligand gene polymorphisms associated with preeclampsia? Pregnancy Hypertension, 2(3), 307. doi:10.1016/j.preghy.2012.04.237
